Role of Oral Lactoferrin in the treatment of Mild to Moderate Ulcerative Colitis - A Pilot Randomized controlled trial

it is a pilot , placebo controlled , double blind , randomized controlled trial to be conducted in the  department of gastroenterology at IMS BHU, Varanasi. The purpose  of the study is to determine the role of oral lactoferrin in the treatment of mild to moderate ulcerative colitis. The study is approved by the institutional ethics committee at IMS BHU.  Patients ,aged 18-60 years ,having mild to moderate ulcerative colitis and presenting to gastroenterology OPD , will be enrolled in the study  after applying inclusion and exclusion criteria and  taking written and informed consent of the patient and will be randomized into 2 groups - oral lactoferrin plus standard medical therapy versus standard medical therapy alone and group A will be given oral  lactoferrin in doses of 1 gm/day along with standard medical therapy while group B will be given placebo along with standard medical therapy . both group patient will be followed up for study duration of 3 months and at the end of 3 months, treatment response will be assessed using complete mayo score .